CIK 0001091596 · Non-accelerated filer<br>Smaller reporting company
Nuo Therapeutics, Inc.
Sign in to watch- Ticker
- AURX
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 233011702
- Phone
- 832-236-9060
- Business address
- 8285 EL RIO, SUITE 190, HOUSTON, TX, 77054
- Former names
- Nuo Therapeutics, Inc, CYTOMEDIX INC, AUTOLOGOUS WOUND THERAPY INC, AUTOLOGOUS WOUND TRERAPY INC
- Open-market buys, last 90 days
- $9,539
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,539. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-01-03 | Benson James Director | Grant or award · NONQUALIFIED OPTION TO PURCHASE SHARES OF COMMON STOCK | +40,000 | 350,000 | ||
| 2012-01-03 | WINZER C ERIC Director | Grant or award · NONQUALIFIED OPTION TO PURCHASE SHARES OF COMMON STOCK | +40,000 | 160,000 | ||
| 2012-01-03 | McLoughlin Mark T Director | Grant or award · NONQUALIFIED OPTION TO PURCHASE SHARES OF COMMON STOCK | +40,000 | 356,667 | ||
| 2011-12-01 | VANEK PATRICK PAUL VP of Operations | Grant or award · OPTIONS TO PURCHASE COMMON STOCK | +30,000 | 140,000 | ||
| 2011-12-01 | JORDEN DAVID EMERSON Director | Grant or award · Options to Purchase Shares of Common Stock | +50,000 | 901,065 | ||
| 2011-12-01 | Maslan Andrew Scott Chief Financial Officer | Grant or award · Options to Purchase Shares of Common Stock | +50,000 | 486,282 | ||
| 2011-12-01 | ROSENDALE MARTIN P Chief Executive Officer | Grant or award · Options to purchase shares of common stock | +150,000 | 1,094,181 | ||
| 2011-10-17 | ROSENDALE MARTIN P Chief Executive Officer | Other acquisition | +949 | 94,022 | ||
| 2011-10-17 | Maslan Andrew Scott Chief Financial Officer | Other acquisition | +475 | 69,665 | ||
| 2011-10-17 | JORDEN DAVID EMERSON Director | Other acquisition | +3,793 | 6,236,293 | ||
| 2011-07-15 | Maslan Andrew Scott Chief Financial Officer | Other acquisition | +625 | 69,190 | ||
| 2011-07-15 | ROSENDALE MARTIN P Chief Executive Officer | Other acquisition | +1,250 | 93,073 | ||
| 2011-07-15 | JORDEN DAVID EMERSON Director | Other acquisition | +5,000 | 6,232,500 | ||
| 2011-06-07 | JORDEN DAVID EMERSON Director | Purchase | +22,500 | $0.34 | $8K | 6,227,500 |
| 2011-05-23 | Maslan Andrew Scott Chief Financial Officer | Grant or award · Options to Purchase Shares of Common Stock | +10,000 | 436,282 | ||
| 2011-05-20 | JORDEN DAVID EMERSON Director | Purchase | +15,000 | $0.38 | $6K | 6,205,000 |
| 2011-05-19 | JORDEN DAVID EMERSON Director | Purchase | +22,500 | $0.39 | $9K | 6,190,000 |
| 2011-05-04 | JORDEN DAVID EMERSON Director | Purchase | +17,500 | $0.36 | $6K | 6,167,500 |
| 2011-05-03 | JORDEN DAVID EMERSON Director | Purchase | +18,000 | $0.35 | $6K | 6,150,000 |
| 2011-05-02 | JORDEN DAVID EMERSON Director | Purchase | +33,666 | $0.36 | $12K | 6,132,000 |
Page 15 of 22 · 436 trades